Trails Edge Capital Partners, LP / 430
Trails Edge Capital Partners, LP’s Terns Pharmaceuticals Inc Position
Does Trails Edge Capital Partners, LP own Terns Pharmaceuticals Inc (430)? Not currently — the last reported position was 300.0K shares worth $12M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$12M
Q4 2025
Shares
300.0K
% of Portfolio
+2.99%
Quarters Held
1
position exited
Position History 430
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 300.0K | $12M | +2.99% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of 430.